Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103195-35-3

Post Buying Request

103195-35-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103195-35-3 Usage

Description

Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate is a coumarin derivative with the chemical formula C13H11NO4. It is an aromatic compound that features a benzene moiety fused to a 2-pyrone through a carbon-carbon bond. This organic compound is known for its potential pharmacological properties and is commonly utilized in the pharmaceutical industry for drug synthesis.

Uses

Used in Pharmaceutical Industry:
Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate serves as a key intermediate in the synthesis of various drugs. Its unique structure and pharmacological properties make it a valuable compound for the development of new medications.
Used in Medical Research:
Due to its anti-inflammatory, antioxidant, and anticancer activities, ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate is used as a subject of study in medical research. Scientists explore its potential applications in treating various diseases and conditions, as well as its mechanisms of action.
Used in Agriculture:
Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate may have potential applications in agriculture, possibly as a component in the development of new pesticides or as a means to enhance crop yields and resistance to diseases.
Used in Industrial Chemistry:
ethyl 8-aMino-4-oxo-4H-chroMene-2-carboxylate could be utilized in industrial chemistry for various purposes, such as the synthesis of specialty chemicals, dyes, or other products that require its unique structural and functional attributes.
Used in Material Science:
Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate may also find applications in material science, where its properties could be harnessed to develop new materials with specific characteristics, such as improved stability, reactivity, or other desirable traits.

Check Digit Verification of cas no

The CAS Registry Mumber 103195-35-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,1,9 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 103195-35:
(8*1)+(7*0)+(6*3)+(5*1)+(4*9)+(3*5)+(2*3)+(1*5)=93
93 % 10 = 3
So 103195-35-3 is a valid CAS Registry Number.

103195-35-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate

1.2 Other means of identification

Product number -
Other names 8-amino-2-ethoxycarbonyl-4-oxo-4H-1-benzopyran

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103195-35-3 SDS

103195-35-3Relevant articles and documents

Malonic acid receptors with decarboxylative activity

Raposo, Cesar,Luengo, Alicia,Almaraz, Marta,Martin, Mercedes,Mussons, M. Luisa,Caballero, M. Cruz,Moran, Joaquin R.

, p. 12323 - 12332 (1996)

The geometry and electronic properties of several malonic acids receptors are studied with a view to optimizing their decarboxylative activity.

Selective Optimization of Pranlukast to Farnesoid X Receptor Modulators

Schierle, Simone,Schmidt, Jurema,Kaiser, Astrid,Merk, Daniel

, p. 2530 - 2545 (2018/11/25)

Selective optimization of side activities (SOSA) offers an alternative entry to early drug discovery and may provide rapid access to bioactive new chemical entities with desirable properties. SOSA aims to reverse a drug's side activities through structural modification and to design out the drug's original main action. We identified a moderate side activity for the cysteinyl leukotriene receptor 1 (CysLT1R) antagonist pranlukast on the farnesoid X receptor (FXR). Systematic structural modification of the drug allowed remarkable optimization of its partial FXR agonism to sub-nanonmolar potency. The resulting FXR modulators lack any activity on CysLT1R and are characterized by high selectivity, high metabolic stability, and low toxicity. With their favorable in vitro profile, these SOSA-derived FXR modulators constitute a new FXR ligand chemotype that appears suitable for further preclinical evaluation.

PROCESS FOR PRODUCING CHROMONE COMPOUND

-

Page 24, 25, (2008/06/13)

A process for producing a dicarboxylic acid compound represented by the formula (4): wherein R1 and R2 are the same or different and each represents lower alkyl and the wavy line indicates that this compound is the E- or Z-isomer or

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103195-35-3